Kinesiotaping for Normalizing Scapular Dyskinesis

Kinesiotaping for Normalizing Scapular Dyskinesis : the Influence on Scapular Kinematics and on the Activity of Scapular Stabilizing Muscles

The 3-dimensional position and orientation of the scapula as well as muscle activation of upper trapezius (UT), lower trapezius (LT) and serratus anterior (SA) of asymptomatic dyskinetic sportspeole will be recorded during shoulder flexion and shoulder abduction, in loaded and unloaded conditions. Participants will be assessed in standard condition and with two differents kinesiotaping techniques.

Study Overview

• Status: Completed
• Conditions: Scapular Dyskinesis
• Intervention / Treatment: Other: Kinesiotaping

Detailed Description

About 20 dyskinetic asymptomatic people will be involved in the study. The objective will be to compare two different kinesiotaping techniques in normalizing scapular kinematics.

Tridimensional-movement of the scapula and EMG activity of periscapular muscles will be evaluated doing flexion (sagittal plane) and abduction (frontal plane) movements.

EMG acquisitions :

The electromyographic (EMG) signals are collected with Trigno Standard and Trigno Mini wireless sensors (Delsys, Boston, MA, USA) using silver-contact bipolar bar electrodes with fixed 10 mm inter-electrode spacing [49]. Three of the main scapular stabilizing muscles of the shoulder are investigated: upper trapezius, lower trapezius and serratus anterior. Electrodes are placed on the dyskinetic side. In case of bilateral scapular dyskinesis, electrodes are placed on the side where the most important dysfunction was observed. Data are acquired at a sample frequency of 1000 Hz.

Tridimensionnal assessment:

Scapular kinematics is assessed using a three-dimensional motion analysis system, an optoelectronic system based on active markers (Codamotion, Charnwood Dynamic, UK). For that purpose, four Codamotion CX1 units are used, at a sampling of 100 Hz. Fifteen active markers were placed on the skin of the subject on the same side as EMG electrodes: 4 on the thorax, 6 on the scapula, 4 on the arm and 1 on the acromio-clavicular joint.

Procedure :

• Warm up : 2x10 shoulder internal and external rotations
• Maximum voluntary isometric contraction (MVIC)
• 10 mouvements of abduction (frontal plane) + 10 mouvements of flexion (sagittal plane), with and without load in each condition (without kinesiotaping, with a first kinesiotaping technique and with a second kinesiotaping technique). The order of the different conditions will be randomised.

• Study Type: Observational
• Enrollment (Actual): 20

Contacts and Locations

Study Locations

• Belgium
  • Liège, Belgium, 4000
    • Laboratoire d'Analyse du Mouvement Humain

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years to 31 years (Adult)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: Male

• Sampling Method: Non-Probability Sample

Study Population

Male dyskinetic sportspeople without shoulder pain, from sportsclub in the Province of Liege (Belgium)

Description

Inclusion Criteria:

• unilateral or bilateral scapular dyskinesis (visual evaluation, "yes-no method")
• scapular downward rotation at rest

Exclusion Criteria:

• asymmetry of length of lower limbs
• scoliosis or dorsal hyperkyphosis shoulder surgical history
• shoulder pain, shoulder injury (muscular, osseous, ligamentary, tendinous) or positive tendinous and impingement tests (Jobe, Patte 0°, Patte 90°, Lift off Test, Palm-up Test).

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
EMG activity of upper trapezius, lower trapezius and serratus anterior	Measurement with Delsys Trigno (non invasive electrodes)	in standard condition and with kinesiotaping (all the same day)

Collaborators and Investigators

• Sponsor: University of Liege

Study record dates

Study Major Dates

• Study Start (Actual): February 1, 2019
• Primary Completion (Actual): April 15, 2019
• Study Completion (Actual): April 15, 2019

Study Registration Dates

• First Submitted: January 25, 2019
• First Submitted That Met QC Criteria: January 25, 2019
• First Posted (Actual): January 30, 2019

Study Record Updates

• Last Update Posted (Actual): May 6, 2019
• Last Update Submitted That Met QC Criteria: May 3, 2019
• Last Verified: May 1, 2019

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Central Nervous System Diseases; Nervous System Diseases; Neurologic Manifestations; Movement Disorders; Dyskinesias
• Other Study ID Numbers: 1 (Other Identifier: Mobile Health and Wellness Program)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No
• IPD Plan Description: Data won't be shared with anyone

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No